RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

2021 ◽  
Author(s):  
Matthew Stevenson ◽  
Ankita Srivastava ◽  
Jenny Lee ◽  
Christopher Hall ◽  
Thomas Palaia ◽  
...  
Keyword(s):  
High Fat ◽  
2021 ◽  
Vol 35 (S1) ◽  
Author(s):  
Courtney Clyburn ◽  
R. Alberto Travagli ◽  
Kirsteen Browning

2008 ◽  
Vol 49 (9) ◽  
pp. 1936-1945 ◽  
Author(s):  
Donatella Gniuli ◽  
Alessandra Calcagno ◽  
Maria Emiliana Caristo ◽  
Alessandra Mancuso ◽  
Veronica Macchi ◽  
...  

2011 ◽  
Vol 85 (Suppl_1) ◽  
pp. 311-311
Author(s):  
Melissa Suter ◽  
Min Hu ◽  
Lori Showalter ◽  
Cynthia Shope ◽  
Kevin Grove ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2136-P
Author(s):  
JOSEPH ELSAKR ◽  
PAUL KIEVIT ◽  
ALVIN C. POWERS ◽  
MAUREEN A. GANNON ◽  
RITA BOTTINO ◽  
...  

2016 ◽  
Vol 23 (9) ◽  
pp. 677-690 ◽  
Author(s):  
Maria Theresa E Montales ◽  
Stepan B Melnyk ◽  
Shi J Liu ◽  
Frank A Simmen ◽  
Y Lucy Liu ◽  
...  

The emerging links between breast cancer and metabolic dysfunctions brought forth by the obesity pandemic predict a disproportionate early disease onset in successive generations. Moreover, sensitivity to chemotherapeutic agents may be influenced by the patient’s metabolic status that affects the disease outcome. Maternal metabolic stress as a determinant of drug response in progeny is not well defined. Here, we evaluated mammary tumor response to doxorubicin in female mouse mammary tumor virus–Wnt1 transgenic offspring exposed to a metabolically compromised environment imposed by maternal high-fat diet. Control progeny were from dams consuming diets with regular fat content. Maternal high-fat diet exposure increased tumor incidence and reduced tumor latency but did not affect tumor volume response to doxorubicin, compared with control diet exposure. However, doxorubicin-treated tumors from high-fat-diet-exposed offspring demonstrated higher proliferation status (Ki-67), mammary stem cell-associated gene expression (Notch1, Aldh1) and basal stem cell-like (CD29hiCD24+) epithelial subpopulation frequencies, than tumors from control diet progeny. Notably, all epithelial subpopulations (CD29hiCD24+, CD29loCD24+, CD29hiCD24+Thy1+) in tumors from high-fat-diet-exposed offspring were refractory to doxorubicin. Further, sera from high-fat-diet-exposed offspring promoted sphere formation of mouse mammary tumor epithelial cells and of human MCF7 cells. Untargeted metabolomics analyses identified higher levels of kynurenine and 2-hydroxyglutarate in plasma of high-fat diet than control diet offspring. Kynurenine/doxorubicin co-treatment of MCF7 cells enhanced the ability to form mammosphere and decreased apoptosis, relative to doxorubicin-only-treated cells. Maternal metabolic dysfunctions during pregnancy and lactation may be targeted to reduce breast cancer risk and improve early drug response in progeny, and may inform clinical management of disease.


2018 ◽  
Vol 9 ◽  
Author(s):  
Cadence True ◽  
Anam Arik ◽  
Sarah Lindsley ◽  
Melissa Kirigiti ◽  
Elinor Sullivan ◽  
...  

2015 ◽  
Vol 152 ◽  
pp. 363-371 ◽  
Author(s):  
Zachary A. Cordner ◽  
Kellie L.K. Tamashiro
Keyword(s):  
High Fat ◽  

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Yuko Maejima ◽  
Shoko Yokota ◽  
Shoichiro Horita ◽  
Kenju Shimomura

Sign in / Sign up

Export Citation Format

Share Document